tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

VSTM Stock Latest News

Verastem’s Phase 3 Study on Avutometinib and Defactinib: A Potential Game-Changer for Ovarian Cancer Treatment
Company AnnouncementsVerastem’s Phase 3 Study on Avutometinib and Defactinib: A Potential Game-Changer for Ovarian Cancer Treatment
3d ago
VSTM
Verastem’s Promising Phase 3 Study on Recurrent Ovarian Cancer
PremiumCompany Announcements
Verastem’s Promising Phase 3 Study on Recurrent Ovarian Cancer
5d ago
VSTM
Verastem announces Nature Medicine publication of FRAME results
PremiumThe Fly
Verastem announces Nature Medicine publication of FRAME results
7d ago
VSTM
Verastem’s Promising Phase 3 Study on Avutometinib and Defactinib in Ovarian Cancer
PremiumCompany Announcements
Verastem’s Promising Phase 3 Study on Avutometinib and Defactinib in Ovarian Cancer
7d ago
VSTM
Verastem price target lowered to $12 from $16 at RBC Capital
PremiumThe Fly
Verastem price target lowered to $12 from $16 at RBC Capital
12d ago
VSTM
Closing Bell Movers: FedEx slips 5% after results and guidance
PremiumThe FlyClosing Bell Movers: FedEx slips 5% after results and guidance
13d ago
BB
FDX
Verastem announces first patient dosed with VS-7375
Premium
The Fly
Verastem announces first patient dosed with VS-7375
13d ago
VSTM
Verastem’s Strategic Growth and Promising Clinical Data Drive Buy Rating
Premium
Ratings
Verastem’s Strategic Growth and Promising Clinical Data Drive Buy Rating
1M ago
VSTM
Promising Clinical Developments and Strong Valuation Support Buy Rating for Verastem
PremiumRatings
Promising Clinical Developments and Strong Valuation Support Buy Rating for Verastem
1M ago
VSTM
Verastem’s Promising Clinical Advances and Strategic Developments Justify Buy Rating
PremiumRatings
Verastem’s Promising Clinical Advances and Strategic Developments Justify Buy Rating
1M ago
VSTM
Verastem Announces Strategic Plans in Investor Webcast
PremiumCompany Announcements
Verastem Announces Strategic Plans in Investor Webcast
1M ago
8K
VSTM
Verastem Announces Promising Phase 1 Study Results
PremiumCompany Announcements
Verastem Announces Promising Phase 1 Study Results
1M ago
8K
VSTM
Verastem announces updated data from GenFleet’s Phase 1 GFH375 study
PremiumThe FlyVerastem announces updated data from GenFleet’s Phase 1 GFH375 study
1M ago
VSTM
Verastem Announces Positive RAMP 205 Trial Results
Premium
Company Announcements
Verastem Announces Positive RAMP 205 Trial Results
2M ago
8K
VSTM
Verastem announces positive Phase 1/2 safety and efficacy results in PDAC
Premium
The Fly
Verastem announces positive Phase 1/2 safety and efficacy results in PDAC
2M ago
VSTM
Verastem’s Strategic Focus and FDA Approval Drive Buy Rating
PremiumRatings
Verastem’s Strategic Focus and FDA Approval Drive Buy Rating
2M ago
VSTM
Verastem files to sell 3.43M shares of common stock for holders
PremiumThe Fly
Verastem files to sell 3.43M shares of common stock for holders
2M ago
VSTM
Verastem reports Q1 adjusted EPS (79c), two estimates (77c)
PremiumThe Fly
Verastem reports Q1 adjusted EPS (79c), two estimates (77c)
2M ago
VSTM
Verastem price target raised to $13 from $12 at B. Riley
PremiumThe Fly
Verastem price target raised to $13 from $12 at B. Riley
2M ago
VSTM
Verastem’s Market Potential Boosted by Accelerated Approval of AVMAPKI FAKZYNJA for KRAS Mutant LGSOC
PremiumRatingsVerastem’s Market Potential Boosted by Accelerated Approval of AVMAPKI FAKZYNJA for KRAS Mutant LGSOC
2M ago
VSTM
Verastem price target raised to $16 from $14 at RBC Capital
Premium
The Fly
Verastem price target raised to $16 from $14 at RBC Capital
2M ago
VSTM
Verastem price target raised to $14 from $10 at H.C. Wainwright
Premium
The Fly
Verastem price target raised to $14 from $10 at H.C. Wainwright
2M ago
VSTM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >